Open-label, Multicenter Immunogenicity and Safety Study of MVA-BN Vaccine in Children From 2 Years to Less Than 12 Years of Age Compared to Adults for the Prevention of Smallpox, Mpox, and Related Orthopoxvirus Infections
Clinical trial NCT06549530 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06549530
- Sponsor
- Bavarian Nordic
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-21
- Primary completion
- 2026-05-01
- Enrollment
- 460
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.